Literature DB >> 7054696

An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds.

S J Marx, M F Attie, A M Spiegel, M A Levine, R D Lasker, M Fox.   

Abstract

Four cases of neonatal severe primary hyperparathyroidism occurred in three families; familial hypocalciuric hypercalcemia was present in each kindred. The diagnosis of familial hypocalciuric hypercalcemia was based on the following features; hypercalcemia in many relatives (eight to 16 per kindred), without other features of the multiple endocrine neoplasia syndromes; recognition of hypercalcemia before the age of 10 in one to three relatives; hypocalciuric hypercalcemia in all relatives tested (five to 14 per kindred); and abnormal serum calcium levels despite parathyroidectomy in all additional relatives (one to five per kindred) undergoing this operation. The association of two uncommon syndromes (neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia) in these kindreds suggests that the two syndromes share a common genetic cause within each kindred.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054696     DOI: 10.1056/NEJM198202043060502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

1.  Neonatal severe hyperparathyroidism: further clinical and molecular delineation.

Authors:  Fawziya A Al-Khalaf; Adel Ismail; Ashraf T Soliman; David E C Cole; Tawfeg Ben-Omran
Journal:  Eur J Pediatr       Date:  2010-10-23       Impact factor: 3.183

Review 2.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

3.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.

Authors:  Stephen J Marx; Ninet Sinaii
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M Bai; N Janicic; S Trivedi; S J Quinn; D E Cole; E M Brown; G N Hendy
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Neonatal hyperparathyroidism.

Authors:  B Steinmann; H E Gnehm; A Prader
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

7.  Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy.

Authors:  Simon Waller; Tom Kurzawinski; Lewis Spitz; Rajesh Thakker; Treena Cranston; Simon Pearce; Tim Cheetham; William G van't Hoff
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

8.  Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism.

Authors:  M F Attie; J R Gill; J L Stock; A M Spiegel; R W Downs; M A Levine; S J Marx
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

9.  Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcaemia.

Authors:  H Wilkinson; J James
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

10.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.